(Total Views: 995)
Posted On: 10/30/2020 10:46:58 PM
Post# of 157707
“Highly specific blockade of CCR5 inhibits leukocyte trafficking and reduces mucosal inflammation in murine colitis”
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4974621/
I know OHM has mentioned Crohn’s on the list for Leronlimab. It’s peaked my interest because my friend takes Humira and it’s not as effective as it was in the start of the treatment. Seems like it will help other inflammation problems in the gut.
Leronlimab will probably be much more effective then humira, since it’s just a TNF blocker and has more sides. I really hope Leronlimab targets this on the next year or so.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4974621/
I know OHM has mentioned Crohn’s on the list for Leronlimab. It’s peaked my interest because my friend takes Humira and it’s not as effective as it was in the start of the treatment. Seems like it will help other inflammation problems in the gut.
Leronlimab will probably be much more effective then humira, since it’s just a TNF blocker and has more sides. I really hope Leronlimab targets this on the next year or so.
(0)
(0)
Daniel Rizzo
Founder & CEO | FireGate Biotech™
AI Platform: Lux Veritas™
Federal Whistleblower Case References
• HHS & SEC Whistleblower ID – HL-1412396
• DOJ Investigation Report / Whistleblower ID – 20250705-0001
• NIH Case Reference – CS1137565 ( IC IG / 50 U.S.C. § 3033 )
Website: FireGateBiotech.com
(For official updates and correspondence — I will no longer be posting here or responding via DMs)
Contact FireGate Biotech
— Jeremiah 51:36
Founder & CEO | FireGate Biotech™
AI Platform: Lux Veritas™
Federal Whistleblower Case References
• HHS & SEC Whistleblower ID – HL-1412396
• DOJ Investigation Report / Whistleblower ID – 20250705-0001
• NIH Case Reference – CS1137565 ( IC IG / 50 U.S.C. § 3033 )
Website: FireGateBiotech.com
(For official updates and correspondence — I will no longer be posting here or responding via DMs)
Contact FireGate Biotech
— Jeremiah 51:36
